| Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study C Bezzio, S Saibeni, A Variola, M Allocca, A Massari, V Gerardi, V Casini, ... Gut 69 (7), 1213-1217, 2020 | 347 | 2020 |
| A 2016 panorama of Helicobacter pylori infection: key messages for clinicians. R Pellicano, DG Ribaldone, S Fagoonee, M Astegiano, GM Saracco, ... Panminerva medica 58 (4), 304-317, 2016 | 136 | 2016 |
| Irritable bowel syndrome: the clinical approach. A Adriani, DG Ribaldone, M Astegiano, M Durazzo, GM Saracco, ... Panminerva medica 60 (4), 213-222, 2018 | 115 | 2018 |
| History of inflammatory bowel diseases GC Actis, R Pellicano, S Fagoonee, DG Ribaldone Journal of clinical medicine 8 (11), 1970, 2019 | 114 | 2019 |
| Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct‐acting antiviral agents A Ciancio, R Bosio, S Bo, M Pellegrini, M Sacco, E Vogliotti, G Fassio, ... Journal of medical virology 90 (2), 320-327, 2018 | 109 | 2018 |
| Serum zonulin in patients with inflammatory bowel disease: a pilot study GP Caviglia, F Dughera, DG Ribaldone, C Rosso, ML Abate, R Pellicano, ... Minerva Medica 110, 95-100, 2019 | 97 | 2019 |
| Bone mineral density at diagnosis of celiac disease and after 1 year of gluten-free diet S Pantaleoni, M Luchino, A Adriani, R Pellicano, D Stradella, ... The Scientific World Journal 2014, 2014 | 78 | 2014 |
| Adalimumab therapy improves intestinal dysbiosis in Crohn’s disease DG Ribaldone, GP Caviglia, A Abdulle, R Pellicano, MC Ditto, M Morino, ... Journal of Clinical Medicine 8 (10), 1646, 2019 | 65 | 2019 |
| Dual biological therapy with anti-TNF, vedolizumab or ustekinumab in inflammatory bowel disease: a systematic review with pool analysis DG Ribaldone, R Pellicano, M Vernero, GP Caviglia, GM Saracco, ... Scandinavian Journal of Gastroenterology 54 (4), 407-413, 2019 | 54 | 2019 |
| Dual targeted therapy: a possible option for the management of refractory inflammatory bowel disease G Privitera, S Onali, D Pugliese, S Renna, E Savarino, A Viola, ... Journal of Crohn's and Colitis 15 (2), 335-339, 2021 | 50 | 2021 |
| Physiopathology of intestinal barrier and the role of zonulin GP Caviglia, C Rosso, DG Ribaldone, F Dughera, S Fagoonee, ... Minerva biotecnologica 31 (3), 83-92, 2019 | 49 | 2019 |
| P. 09.10 GLUCOSE BREATH TEST AND CROHN'S DISEASE: DIAGNOSIS OF SMALL INTESTINAL BACTERIAL OVERGROWTH AND EVALUATION OF THERAPEUTIC RESPONSE A Greco, GP Caviglia, DG Ribaldone, P Brignolo, S Reggiani, ... Digestive and Liver Disease 47 (S2), e177, 2015 | 48* | 2015 |
| The usefulness of microencapsulated sodium butyrate add-on therapy in maintaining remission in patients with ulcerative colitis: a prospective observational study M Vernero, F De Blasio, DG Ribaldone, E Bugianesi, R Pellicano, ... Journal of clinical medicine 9 (12), 3941, 2020 | 47 | 2020 |
| Helicobacter pylori in celiac disease and in duodenal intraepithelial lymphocytosis: active protagonist or innocent bystander? D Simondi, DG Ribaldone, GA Bonagura, S Foi, N Sapone, M Garavagno, ... Clinics and research in hepatology and gastroenterology 39 (6), 740-745, 2015 | 42 | 2015 |
| Alpha-fetoprotein, protein induced by vitamin K absence or antagonist II and glypican-3 for the detection and prediction of hepatocellular carcinoma in patients with cirrhosis … GP Caviglia, M Ciruolo, ML Abate, P Carucci, E Rolle, C Rosso, A Olivero, ... Cancers 12 (11), 3218, 2020 | 40 | 2020 |
| Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) G Fiorino, F Caprioli, M Daperno, F Mocciaro, M Principi, A Viscido, ... Digestive and Liver Disease 51 (5), 632-639, 2019 | 40 | 2019 |
| Rifabutin-Based Rescue Therapy for Helicobacter pylori Eradication: A Long-Term Prospective Study in a Large Cohort of Difficult-to-Treat Patients DG Ribaldone, S Fagoonee, M Astegiano, M Durazzo, A Morgando, ... Journal of Clinical Medicine 8 (2), 199, 2019 | 40 | 2019 |
| On-treatment decrease of serum interleukin-6 as a predictor of clinical response to biologic therapy in patients with inflammatory bowel diseases GP Caviglia, C Rosso, F Stalla, M Rizzo, A Massano, ML Abate, A Olivero, ... Journal of Clinical Medicine 9 (3), 800, 2020 | 39 | 2020 |
| Role of bowel ultrasound as a predictor of surgical recurrence of Crohn's disease T Cammarota, DG Ribaldone, A Resegotti, A Repici, S Danese, G Fiorino, ... Scandinavian Journal of Gastroenterology 48 (5), 552-555, 2013 | 39 | 2013 |
| Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis G Colombo, N Clemente, A Zito, C Bracci, FS Colombo, S Sangaletti, ... J Mol Med (Berl), 2020 | 38 | 2020 |
Pellicano RinaldoS.C. Gastroenterologia e Epatologia, Azienda Ospedaliero-Universitaria Molinette, TorinoVerified email at molinette.piemonte.it
